<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ADM2 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>ADM2</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q7Z4H4" target="_blank" class="term-link">
                        Q7Z4H4
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "ADM2";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q7Z4H4" data-a="DESCRIPTION: ADM2 (Adrenomedullin-2/Intermedin) encodes a secre..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>ADM2 (Adrenomedullin-2/Intermedin) encodes a secreted peptide hormone of the calcitonin/CGRP superfamily. The 148 amino acid prepro-protein is proteolytically processed to generate bioactive C-terminal peptides including IMD1-53, IMD1-47, and IMD8-47. ADM2 functions as a ligand for CALCRL/RAMP receptor complexes (AM1, AM2, and CGRP receptors), where RAMP identity determines receptor affinity and signaling bias. Canonical signaling is via Gs-coupled adenylyl cyclase/cAMP pathway, with additional engagement of Gq/Ca2+, ERK, and NOS/NO pathways. ADM2 acts as a potent vasodilator regulating systemic blood pressure, promotes angiogenesis, protects endothelial barrier integrity, and has roles in cardiovascular and renal homeostasis. It functions primarily in autocrine/paracrine mode with low basal plasma levels.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005179" target="_blank" class="term-link">
                                    GO:0005179
                                </a>
                            </span>
                            <span class="term-label">hormone activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005179" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2/Intermedin is a well-established peptide hormone of the calcitonin/CGRP family that signals through CALCRL/RAMP receptor complexes. The IBA annotation is phylogenetically sound and consistent with experimental data showing ADM2 activates cAMP-dependent pathways through these receptors [PMID:14615490, PMID:32296767].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function of ADM2 as a hormone is strongly supported by primary literature. ADM2 is synthesized as a prepropeptide and processed to secreted bioactive peptides that act as ligands for GPCR complexes, fulfilling the definition of hormone activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link">
                                        PMID:32296767
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005615" target="_blank" class="term-link">
                                    GO:0005615
                                </a>
                            </span>
                            <span class="term-label">extracellular space</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005615" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2 is a secreted peptide hormone that functions in the extracellular space to activate CALCRL/RAMP receptors. This is consistent with its signal peptide, secretory pathway processing, and autocrine/paracrine mode of action [PMID:14615490].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The extracellular space localization is correct for a secreted hormone that acts on cell surface receptors. UniProt confirms secreted localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035809" target="_blank" class="term-link">
                                    GO:0035809
                                </a>
                            </span>
                            <span class="term-label">regulation of urine volume</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0035809" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2/Intermedin has documented roles in renal function and diuresis, consistent with the broader adrenomedullin family. The deep research notes ADM2 has cardiopulmonary and renal protective actions [file:human/ADM2/ADM2-deep-research-falcon.md].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ADM2 does affect renal function including urine volume, this represents a downstream physiological consequence of its vasodilatory and blood pressure regulatory effects rather than a core molecular function. The primary role is as a vasoactive hormone signaling through CALCRL/RAMP.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/ADM2/ADM2-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">ADM2/IMD as a potent vasodilator with cardiopulmonary and renal protective actions</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1990410" target="_blank" class="term-link">
                                    GO:1990410
                                </a>
                            </span>
                            <span class="term-label">adrenomedullin receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:1990410" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2 is a bona fide ligand for the adrenomedullin receptors (CALCRL+RAMP2/3). The IBA annotation is phylogenetically supported and consistent with structural and biochemical data showing ADM2 binding and activation of these receptors [PMID:14615490, PMID:32296767].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function of ADM2 is to act as a ligand in the adrenomedullin receptor signaling pathway. This is directly supported by cryo-EM structures of ADM2 in complex with AM2R.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link">
                                        PMID:32296767
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">treatment of 293T cells expressing recombinant calcitonin receptor-like receptor (CRLR) and one of the three receptor activity-modifying proteins (RAMPs) showed that a CRLR/RAMP receptor complex is required for intermedin signaling</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003073" target="_blank" class="term-link">
                                    GO:0003073
                                </a>
                            </span>
                            <span class="term-label">regulation of systemic arterial blood pressure</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0003073" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2/Intermedin is a potent vasodilator that reduces systemic arterial blood pressure. In vivo studies demonstrated blood pressure reduction in both normal and spontaneously hypertensive rats [PMID:14615490].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Blood pressure regulation is a core physiological function of ADM2, directly linked to its vasodilatory activity through CALCRL/RAMP signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats via interactions with the CRLR/RAMP receptor complexes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007189" target="_blank" class="term-link">
                                    GO:0007189
                                </a>
                            </span>
                            <span class="term-label">adenylate cyclase-activating G protein-coupled receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0007189" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2 signals through CALCRL/RAMP receptor complexes coupled to Gs, leading to adenylyl cyclase activation and cAMP production. This is the canonical downstream signaling pathway [PMID:14615490].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This accurately describes the primary signaling mechanism of ADM2. As a ligand for CALCRL/RAMP GPCRs, it triggers Gs-coupled adenylyl cyclase activation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010460" target="_blank" class="term-link">
                                    GO:0010460
                                </a>
                            </span>
                            <span class="term-label">positive regulation of heart rate</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0010460" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2/Intermedin has documented cardiovascular effects including effects on heart rate. The literature indicates ADM2 is important for homeostasis in diverse tissues including cardiovascular [PMID:14615490].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ADM2 does have cardiovascular effects that may include heart rate modulation, this represents a downstream physiological consequence rather than a core molecular function. The primary functions are hormone activity, receptor signaling, and blood pressure regulation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Calcitonin, calcitonin gene-related peptide (CGRP), adrenomedullin (ADM), and amylin belong to a unique group of peptide hormones important for homeostasis in diverse tissues</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005179" target="_blank" class="term-link">
                                    GO:0005179
                                </a>
                            </span>
                            <span class="term-label">hormone activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005179" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This IEA annotation from UniProt keyword mapping correctly identifies ADM2 as having hormone activity. It is redundant with the IBA and IDA annotations for the same term.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct annotation, though redundant with IBA/IDA evidence for the same term. The UniProt keyword mapping is appropriate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin is a calcitonin/calcitonin gene-related peptide family peptide</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005576" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This IEA annotation from UniProt subcellular location mapping correctly places ADM2 in the extracellular region. Consistent with its secreted nature.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct annotation. ADM2 is a secreted protein and functions in the extracellular region. This is a broader parent term of extracellular space (GO:0005615).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007189" target="_blank" class="term-link">
                                    GO:0007189
                                </a>
                            </span>
                            <span class="term-label">adenylate cyclase-activating G protein-coupled receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0007189" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This IEA annotation from Ensembl Compara orthology transfer is consistent with the IBA annotation for the same term. Redundant but correct.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct annotation, redundant with IBA evidence. The orthology-based transfer is appropriate for this conserved signaling function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin increased cAMP production in SK-N-MC and L6 cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007631" target="_blank" class="term-link">
                                    GO:0007631
                                </a>
                            </span>
                            <span class="term-label">feeding behavior</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0007631" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The original PMID:14615490 reports that intermedin treatment in mice led to suppression of food intake, supporting a role in feeding behavior regulation. This IEA is transferred from rat ortholog evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ADM2 does affect feeding behavior (suppresses food intake and gastric emptying per PMID:14615490), this is not a core molecular function but rather a downstream physiological effect of its neuroendocrine activity. The primary function is as a vasoactive hormone.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045776" target="_blank" class="term-link">
                                    GO:0045776
                                </a>
                            </span>
                            <span class="term-label">negative regulation of blood pressure</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0045776" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ADM2 is a potent vasodilator that reduces blood pressure. This is well supported by PMID:14615490 showing blood pressure reduction in normal and hypertensive rats.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct and important annotation. ADM2 is a vasodilator that negatively regulates blood pressure. This is a core physiological function consistent with its role as a vasoactive hormone.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005179" target="_blank" class="term-link">
                                    GO:0005179
                                </a>
                            </span>
                            <span class="term-label">hormone activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296767
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structure and Dynamics of Adrenomedullin Receptors AM(1) and...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005179" data-r="PMID:32296767" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:32296767 provides structural evidence of ADM2 (intermedin) in complex with AM2 receptor and Gs protein at 2.3 angstrom resolution, demonstrating it functions as a hormone ligand for this receptor complex.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Strong structural evidence supporting hormone activity. The cryo-EM structure directly shows ADM2 peptide bound to and activating the receptor complex.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link">
                                        PMID:32296767
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005615" target="_blank" class="term-link">
                                    GO:0005615
                                </a>
                            </span>
                            <span class="term-label">extracellular space</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:14615490
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Intermedin is a calcitonin/calcitonin gene-related peptide f...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005615" data-r="PMID:14615490" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:14615490 demonstrates that intermedin acts on cell surface receptors to activate intracellular signaling (cAMP production), indicating it functions in the extracellular space.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Appropriate localization for a secreted peptide hormone that activates cell surface receptors.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                                        PMID:14615490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors and competed with labeled CGRP for binding to its receptors in these cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1990410" target="_blank" class="term-link">
                                    GO:1990410
                                </a>
                            </span>
                            <span class="term-label">adrenomedullin receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296767
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structure and Dynamics of Adrenomedullin Receptors AM(1) and...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:1990410" data-r="PMID:32296767" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:32296767 provides direct structural evidence of ADM2 bound to the AM2 receptor (CALCRL+RAMP3) in complex with Gs protein, demonstrating its involvement in adrenomedullin receptor signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> High-resolution structural evidence directly demonstrates ADM2 engagement with the adrenomedullin receptor signaling pathway.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link">
                                        PMID:32296767
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-379044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005576" data-r="Reactome:R-HSA-379044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome pathway annotation placing ADM2 in the extracellular region as part of the Gs-activating GPCR signaling complex. Consistent with its role as a secreted hormone ligand.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization. ADM2 is a secreted ligand that functions in the extracellular region where it binds to cell surface receptors.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-420214
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005576" data-r="Reactome:R-HSA-420214" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome annotation specifically documenting that intermedin (ADM2) binds to the adrenomedullin receptor in the extracellular region.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Directly relevant Reactome annotation. The reaction specifically describes ADM2/intermedin binding to adrenomedullin receptors.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-744886
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005576" data-r="Reactome:R-HSA-744886" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome annotation for ligand:GPCR:Gs complex dissociation, placing ADM2 in the extracellular region. Redundant with other extracellular region annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization, though redundant with multiple other annotations for the same term.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-744887
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0005576" data-r="Reactome:R-HSA-744887" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome annotation for liganded Gs-activating GPCRs binding inactive heterotrimeric Gs. Places ADM2 as extracellular ligand.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization, though redundant with multiple other annotations for the same term.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001525" target="_blank" class="term-link">
                                    GO:0001525
                                </a>
                            </span>
                            <span class="term-label">angiogenesis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20596610
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Involvement of vascular endothelial growth factor signaling ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0001525" data-r="PMID:20596610" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:20596610 demonstrates that intermedin (IMD) exerts a pro-angiogenic effect on human vascular endothelial cells cultured on Matrigel, mediated through CLR/RAMP1 and CLR/RAMP2 receptors.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ADM2 does promote angiogenesis, this is a downstream biological process resulting from its signaling activity rather than a core molecular function. The core function is hormone activity through receptor signaling. The more specific term GO:0045766 (positive regulation of angiogenesis) better captures the regulatory nature of this activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link">
                                        PMID:20596610
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">IMD exerted a significant in vitro angiogenic action, specifically triggered by the binding of the peptide to CLR/RAMP complexes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006468" target="_blank" class="term-link">
                                    GO:0006468
                                </a>
                            </span>
                            <span class="term-label">protein phosphorylation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20596610
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Involvement of vascular endothelial growth factor signaling ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0006468" data-r="PMID:20596610" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OVER-ANNOTATION: ADM2 is a secreted peptide hormone that acts as a LIGAND for GPCR receptors (CALCRL/RAMP complexes). It has NO kinase activity. PMID:20596610 shows ADM2 treatment leads to increased VEGF receptor-2 phosphorylation, but ADM2 does not catalyze phosphorylation itself - it triggers signaling that leads to kinase activation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation incorrectly implies ADM2 has a direct role in protein phosphorylation. ADM2 is a peptide hormone ligand, not a kinase. The phosphorylation observed in PMID:20596610 (VEGFR-2 phosphorylation) is a downstream consequence of ADM2 signaling, not a direct function of the protein. The GO term &#34;protein phosphorylation&#34; is meant for proteins that catalyze phosphorylation reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link">
                                        PMID:20596610
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Western blot analysis, however, showed a significant increase of VEGF receptor-2 phosphorylation as early as 5 min following IMD administration</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010628" target="_blank" class="term-link">
                                    GO:0010628
                                </a>
                            </span>
                            <span class="term-label">positive regulation of gene expression</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20596610
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Involvement of vascular endothelial growth factor signaling ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0010628" data-r="PMID:20596610" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:20596610 shows that intermedin treatment leads to increased VEGF mRNA expression 18h after administration, indicating positive regulation of gene expression.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ADM2 does positively regulate gene expression (e.g., VEGF), this is a downstream consequence of its receptor signaling activity rather than a core molecular function. The term is also quite broad; a more specific annotation regarding VEGF expression would be more informative.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link">
                                        PMID:20596610
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">a significant increase of vascular endothelial growth factor (VEGF) mRNA expression 18 h following IMD administration</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0044877" target="_blank" class="term-link">
                                    GO:0044877
                                </a>
                            </span>
                            <span class="term-label">protein-containing complex binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20596610
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Involvement of vascular endothelial growth factor signaling ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0044877" data-r="PMID:20596610" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation likely refers to ADM2 binding to the CALCRL/RAMP receptor complex. While technically accurate, &#34;protein-containing complex binding&#34; is a very general term that does not adequately describe the specific hormone-receptor interaction.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This term is too vague and uninformative. ADM2 specifically binds to CALCRL/RAMP receptor complexes as a hormone ligand. The &#34;hormone activity&#34; annotation better captures this function. If a binding term is needed, a more specific term like G protein-coupled receptor binding would be more appropriate, though the hormone activity annotation already implies receptor binding.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001664" target="_blank" class="term-link">
                                    G protein-coupled receptor binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link">
                                        PMID:20596610
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">IMD exerted a significant in vitro angiogenic action, specifically triggered by the binding of the peptide to CLR/RAMP complexes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045766" target="_blank" class="term-link">
                                    GO:0045766
                                </a>
                            </span>
                            <span class="term-label">positive regulation of angiogenesis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19592612" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19592612
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Intermedin is a new angiogenic growth factor.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q7Z4H4" data-a="GO:0045766" data-r="PMID:19592612" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:19592612 provides strong evidence that intermedin promotes angiogenesis through multiple mechanisms including increased blood perfusion, capillary and arteriole density in ischemic hindlimb, endothelial cell migration and tube formation, mediated via ERK, Akt/NOS/NO, and VEGF/VEGFR-2 pathways.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ADM2 does positively regulate angiogenesis, which is a significant biological function. However, this represents a downstream effect of its hormone signaling activity rather than the core molecular function. The primary functions are hormone activity and receptor signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19592612" target="_blank" class="term-link">
                                        PMID:19592612
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">IMD gene delivery also increased capillary and arteriole density in ischemic hindlimb</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19592612" target="_blank" class="term-link">
                                        PMID:19592612
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">In cultured endothelial cells, IMD induced cell migration and tube formation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>ADM2 is fundamentally a peptide hormone. It is synthesized as a prepropeptide, proteolytically processed to bioactive fragments, secreted, and acts on target cells through cell surface receptors. This is supported by IBA, IEA, and IDA evidence including cryo-EM structures showing ADM2 bound to receptor complexes.</h3>
                <span class="vote-buttons" data-g="Q7Z4H4" data-a="FUNCTION: ADM2 is fundamentally a peptide hormone. It is syn..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005179" target="_blank" class="term-link">
                            hormone activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1990410" target="_blank" class="term-link">
                                adrenomedullin receptor signaling pathway
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007189" target="_blank" class="term-link">
                                adenylate cyclase-activating G protein-coupled receptor signaling pathway
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003073" target="_blank" class="term-link">
                                regulation of systemic arterial blood pressure
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005615" target="_blank" class="term-link">
                                extracellular space
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14615490" target="_blank" class="term-link">
                            PMID:14615490
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ADM2/Intermedin is a novel member of the calcitonin/CGRP peptide family</div>
                        
                        <div class="finding-text">"Intermedin is a calcitonin/calcitonin gene-related peptide family peptide"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Expressed primarily in pituitary and gastrointestinal tract</div>
                        
                        <div class="finding-text">"intermedin is expressed primarily in the pituitary and gastrointestinal tract"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Signals through CRLR/RAMP receptor complexes</div>
                        
                        <div class="finding-text">"a CRLR/RAMP receptor complex is required for intermedin signaling"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Increases cAMP production</div>
                        
                        <div class="finding-text">"Intermedin increased cAMP production in SK-N-MC and L6 cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Acts as a nonselective agonist for RAMP coreceptors</div>
                        
                        <div class="finding-text">"intermedin represents a nonselective agonist for the RAMP coreceptors"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Reduces blood pressure in normal and hypertensive rats</div>
                        
                        <div class="finding-text">"intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Suppresses gastric emptying and food intake</div>
                        
                        <div class="finding-text">"in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19592612" target="_blank" class="term-link">
                            PMID:19592612
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Intermedin is a new angiogenic growth factor.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IMD promotes angiogenesis in ischemic hindlimb</div>
                        
                        <div class="finding-text">"IMD gene delivery also increased capillary and arteriole density in ischemic hindlimb"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Increases capillary and arteriole density</div>
                        
                        <div class="finding-text">"increased capillary and arteriole density in ischemic hindlimb, identified by anti-CD-31 and alpha-smooth muscle actin immunostaining"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Induces endothelial cell migration and tube formation</div>
                        
                        <div class="finding-text">"In cultured endothelial cells, IMD induced cell migration and tube formation"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Effects mediated via ERK, Akt/NOS/NO, and VEGF/VEGFR-2 pathways</div>
                        
                        <div class="finding-text">"these effects were blocked by the inhibition of extracellular signal-regulated kinase (ERK), Akt, nitric oxide (NO) synthase (NOS), vascular endothelial growth factor receptor-2 (VEGFR-2)"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20596610" target="_blank" class="term-link">
                            PMID:20596610
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IMD exerts pro-angiogenic effects on HUVECs</div>
                        
                        <div class="finding-text">"IMD exerted a significant in vitro angiogenic action"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Mediated through CLR/RAMP1 and CLR/RAMP2 receptors</div>
                        
                        <div class="finding-text">"Both CLR/RAMP1 and CLR/RAMP2 appeared to mediate the pro-angiogenic effect"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Increases VEGF mRNA expression</div>
                        
                        <div class="finding-text">"a significant increase of vascular endothelial growth factor (VEGF) mRNA expression 18 h following IMD administration"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Induces VEGFR-2 phosphorylation</div>
                        
                        <div class="finding-text">"a significant increase of VEGF receptor-2 phosphorylation as early as 5 min following IMD administration"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296767" target="_blank" class="term-link">
                            PMID:32296767
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Structure and Dynamics of Adrenomedullin Receptors AM(1) and AM(2) Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Cryo-EM structure of AM2R in complex with intermedin/ADM2 at 2.3 angstrom</div>
                        
                        <div class="finding-text">"structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Reveals mechanisms of RAMP modulation of CLR phenotype</div>
                        
                        <div class="finding-text">"Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Structural basis for ligand recognition</div>
                        
                        <div class="finding-text">"The structures reveal distinctions in the primary orientation of the extracellular domains (ECDs) relative to the receptor core"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-379044
                        
                    </span>
                </div>
                
                <div class="reference-title">Liganded Gs-activating GPCR acts as a GEF for Gs</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-420214
                        
                    </span>
                </div>
                
                <div class="reference-title">The adrenomedullin receptor can bind adrenomedullin and intermedin</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-744886
                        
                    </span>
                </div>
                
                <div class="reference-title">The Ligand:GPCR:Gs complex dissociates</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-744887
                        
                    </span>
                </div>
                
                <div class="reference-title">Liganded Gs-activating GPCRs bind inactive heterotrimeric Gs</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/ADM2/ADM2-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on ADM2 gene</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ADM2 has cardiopulmonary and renal protective actions</div>
                        
                        <div class="finding-text">"ADM2/IMD as a potent vasodilator with cardiopulmonary and renal protective actions"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(ADM2-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q7Z4H4" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2026-02-08T20:24:18.942473'<br />
end_time: '2026-02-08T20:32:21.044244'<br />
duration_seconds: 482.1<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: ADM2<br />
  gene_symbol: ADM2<br />
  uniprot_accession: Q7Z4H4<br />
  protein_description: 'RecName: Full=Protein ADM2; AltName: Full=Intermedin {ECO:0000303|PubMed:14615490};<br />
    Contains: RecName: Full=Adrenomedullin-2 {ECO:0000303|PubMed:16359754}; Short=AM2;<br />
    AltName: Full=Intermedin-long; Short=IMDL; Contains: RecName: Full=Intermedin-short;<br />
    Short=IMDS; Flags: Precursor;'<br />
  gene_info: Name=ADM2 {ECO:0000312|HGNC:HGNC:28898}; Synonyms=AM2;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the adrenomedullin family. .<br />
  protein_domains: Adrenomedullin-reg_peptide. (IPR051665)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 45</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q7Z4H4</li>
<li><strong>Protein Description:</strong> RecName: Full=Protein ADM2; AltName: Full=Intermedin {ECO:0000303|PubMed:14615490}; Contains: RecName: Full=Adrenomedullin-2 {ECO:0000303|PubMed:16359754}; Short=AM2; AltName: Full=Intermedin-long; Short=IMDL; Contains: RecName: Full=Intermedin-short; Short=IMDS; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=ADM2 {ECO:0000312|HGNC:HGNC:28898}; Synonyms=AM2;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adrenomedullin family. .</li>
<li><strong>Key Domains:</strong> Adrenomedullin-reg_peptide. (IPR051665)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ADM2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ADM2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ADM2</strong> (gene ID: ADM2, UniProt: Q7Z4H4) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q7Z4H4</li>
<li><strong>Protein Description:</strong> RecName: Full=Protein ADM2; AltName: Full=Intermedin {ECO:0000303|PubMed:14615490}; Contains: RecName: Full=Adrenomedullin-2 {ECO:0000303|PubMed:16359754}; Short=AM2; AltName: Full=Intermedin-long; Short=IMDL; Contains: RecName: Full=Intermedin-short; Short=IMDS; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=ADM2 {ECO:0000312|HGNC:HGNC:28898}; Synonyms=AM2;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the adrenomedullin family. .</li>
<li><strong>Key Domains:</strong> Adrenomedullin-reg_peptide. (IPR051665)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ADM2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ADM2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ADM2</strong> (gene ID: ADM2, UniProt: Q7Z4H4) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan<br />
- Verify identity and resolve potential symbol ambiguity using human-focused, authoritative sources (UniProt description cross-checked against human literature). Collect and synthesize 2023‚Äì2024 developments on ADM2/CALCRL‚ÄìRAMP signaling, structure, genetics, and metabolism. Summarize molecular function, processing, receptors, signaling, localization/expression, and precise physiological roles. Document translational/clinical implementations (biomarkers, therapeutic strategies) and pregnancy/placenta roles. Provide quantitative data where available, prioritize recent, peer‚Äëreviewed sources, and include URLs and publication dates.</p>
<p>Verification of Target Identity and Nomenclature<br />
- Target: Human ADM2 (adrenomedullin‚Äë2), also known as intermedin (IMD), encoded on human chromosome 22q13.33; UniProt Q7Z4H4 corresponds to a 148‚Äëaa prepro‚Äëpeptide processed to biologically active C‚Äëterminal fragments. ADM2 belongs to the calcitonin/CGRP peptide family and functions as a secreted regulatory peptide. These features are consistent with the UniProt brief and with authoritative human literature; no conflicting non‚Äëhuman gene symbol usage was used for this report. (https://doi.org/10.1111/bph.13814, Apr 2018; https://doi.org/10.1038/sj.bjp.0707494, Mar 2008; https://doi.org/10.1007/s11427-014-4701-7, Aug 2014) (zhang2018adrenomedullin2intermedina pages 1-3, bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2, ni2014intermedinadrenomedullin2anautocrineparacrine pages 1-2)</p>
<p>Key concepts and definitions<br />
- Molecular identity and processing. ADM2/IMD is synthesized as prepro‚ÄëIMD (~148 aa) and proteolytically processed to multiple active C‚Äëterminal peptides, notably IMD1‚Äì53, IMD1‚Äì47, and IMD8‚Äì47; fragments display distinct bioactivities across CLR/RAMP receptor subtypes. Dibasic cleavage sites have been mapped in mammals; IMD1‚Äì53 and IMD8‚Äì47 are established as physiologically relevant forms. (https://doi.org/10.1038/sj.bjp.0707494, Mar 2008; https://doi.org/10.1007/s11427-014-4701-7, Aug 2014; https://doi.org/10.1111/bph.13814, Apr 2018) (bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2, ni2014intermedinadrenomedullin2anautocrineparacrine pages 1-2, zhang2018adrenomedullin2intermedina pages 1-3)<br />
- Receptors and selectivity. ADM2 signals via the class B1 GPCR calcitonin receptor‚Äëlike receptor (CALCRL/CLR) in complex with receptor activity‚Äëmodifying proteins (RAMPs): CLR+RAMP2 (AM1 receptor), CLR+RAMP3 (AM2 receptor), and CLR+RAMP1 (CGRP receptor). RAMP identity governs trafficking, ligand affinity/selectivity and signaling bias. Relative to CGRP and ADM, ADM2 shows distinct potency profiles across these complexes. (https://doi.org/10.1007/s11427-014-4701-7, Aug 2014; https://doi.org/10.1111/bph.13814, Apr 2018; https://doi.org/10.1038/sj.bjp.0707494, Mar 2008) (ni2014intermedinadrenomedullin2anautocrineparacrine pages 2-4, zhang2018adrenomedullin2intermedina pages 3-4, bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2)<br />
- Downstream signaling. Canonical coupling is Gs‚Üíadenylyl cyclase‚ÜícAMP/PKA; additional pathways include Gq/PLCŒ≤‚ÜíCa2+, ERK activation, and NO generation via L‚Äëarginine transport and eNOS, linking to cGMP signaling and endothelial function. RAMP composition can bias G‚Äëprotein usage and downstream pathways. (https://doi.org/10.1007/s11427-014-4701-7, Aug 2014; https://doi.org/10.1111/bph.13814, Apr 2018) (ni2014intermedinadrenomedullin2anautocrineparacrine pages 2-4, zhang2018adrenomedullin2intermedina pages 3-4)<br />
- Structural/biophysical family features. Members of the calcitonin/CGRP family share an N‚Äëterminal disulfide‚Äëbonded loop and helical core; receptor recognition predominantly involves the C‚Äëterminal region in a two‚Äëdomain binding mode typical of class B GPCRs. These features rationalize ADM/ADM2 pharmacology at CLR/CTR‚ÄìRAMP complexes. (https://doi.org/10.1002/psc.2953, Jul 2017) (schonauer2017adrenomedullin‚Äìnew pages 2-2)</p>
<p>Recent developments and latest research (2023‚Äì2024 emphasis)<br />
- RAMPs as allosteric modulators and determinants of bias. A 2024 review synthesizes data showing RAMPs alter GPCR phenotype, ligand preference, signaling bias, trafficking and recycling, extending beyond CLR/CTR to other class B1 GPCRs; these insights solidify that pharmacology of ADM2 is context‚Äëdependent on RAMP isoform and expression in metabolic tissues. Human Protein Atlas‚Äëbased mapping (accessed 2024) supports tissue‚Äëspecific RAMP distributions relevant for ADM2 actions. (https://doi.org/10.1530/jme-24-0056, Sep 2024) (malcharek2024theroleof pages 31-35, malcharek2024theroleof pages 35-42, malcharek2024theroleof pages 21-26)<br />
- Human CALCRL variants. A 2024 thesis characterizes a naturally occurring CALCRL variant (I446T; rs369317777) enriched in Polynesian populations: prior overexpression assays suggested minimal effects, but more physiological constructs and iPSC‚Äëderived endothelial models revealed reduced AM‚Äëinduced cAMP efficacy; ADM2 was included among ligands tested. Clinically, carriers showed lower systolic blood pressure, but in diabetes had worse kidney outcomes, supporting physiologic relevance of variant‚Äëdependent CLR signaling. (2024 thesis; institutional repository, includes primary data and literature synthesis) (reith2024characterisationofa pages 8-14, reith2024characterisationofa pages 23-27)<br />
- Structural context. Recent syntheses referenced by 2024 works emphasize cryo‚ÄëEM/structural studies resolving CLR/RAMP complexes and G‚Äëprotein coupling that explain RAMP‚Äëdependent receptor phenotype for CGRP/AM/AM2 receptors, strengthening mechanistic bases for ADM2 selectivity and bias. (2024 compilation citing Liang et al. 2018/2020) (reith2024characterisationofa pages 91-93)<br />
- Metabolic relevance and RAMP expression. 2024 analysis compiles evidence that ADM2 supports adipose browning/beiging, improves insulin resistance and energy expenditure in rodent models, and that RAMP isoform balance (e.g., RAMP3 loss) modulates obesity phenotypes‚Äîtogether indicating therapeutic potential at specific CLR/RAMP complexes in metabolic disease. (https://doi.org/10.1530/jme-24-0056, Sep 2024) (malcharek2024theroleof pages 13-17)<br />
- Overall interpretation. 2023‚Äì2024 literature refines rather than overturns ADM2 pharmacology: it underscores RAMP‚Äëdetermined receptor context, highlights genetic variation affecting signaling, and extends relevance to metabolism, aligning with earlier proposals of receptor‚Äëcomplex‚Äëspecific therapeutic strategies. (https://doi.org/10.1530/jme-24-0056, Sep 2024; 2024 thesis) (malcharek2024theroleof pages 31-35, malcharek2024theroleof pages 35-42, reith2024characterisationofa pages 23-27)</p>
<p>Current applications and real‚Äëworld implementations<br />
- Biomarkers. Two clinically used assay paradigms target the ADM axis: MR‚ÄëproADM (stable mid‚Äëregional pro‚Äëfragment) and bio‚ÄëADM (assay for biologically active ADM). Bio‚ÄëADM is elevated in cardiogenic shock and acute decompensated heart failure (ADHF), correlates with clinical congestion, and predicts 60‚Äëday HF re‚Äëhospitalization when measured at baseline and day 7 in ED/ADHF cohorts. (https://doi.org/10.1002/ejhf.1366, Dec 2019) (voors2019adrenomedullininheart pages 3-4)<br />
- Therapeutics modulating the ADM axis. Adrecizumab is a humanized, non‚Äëneutralizing monoclonal antibody that binds the N‚Äëterminus of ADM, increasing intravascular ADM and stabilizing endothelial barrier function while limiting interstitial vasodilatory effects; early clinical testing in systemic inflammation/LPS challenge showed symptom score reduction, and a sepsis program was initiated. HF translation has been proposed given bio‚ÄëADM‚Äôs link to congestion, though clinical efficacy data in HF remain limited. (https://doi.org/10.3389/fimmu.2018.00292, Feb 2018; https://doi.org/10.1002/ejhf.1366, Dec 2019) (geven2018adrenomedullinandadrenomedullintargeted pages 1-2, voors2019adrenomedullininheart pages 6-7, voors2019adrenomedullininheart pages 6-6)<br />
- Pregnancy/placental context. In human placenta, ADM2 is expressed in cytotrophoblasts, syncytiotrophoblasts and endothelial cells, promotes trophoblast invasion/migration, and stimulates NO; second‚Äëtrimester amniotic fluid ADM2 was lower in women who later developed early preeclampsia (n=17 vs 12 controls), and ADM2‚ÄìCRLR proximity was reduced in preeclamptic villous tissue, indicating a pathophysiologic association with defective placentation. (https://doi.org/10.1095/biolreprod.108.074419, Oct 2009; https://doi.org/10.1210/jc.2016-1333, Sep 2016) (chauhan2009expressionofadrenomedullin pages 2-3, chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 6-7, chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 2-3)</p>
<p>Expert opinions and analysis from authoritative sources<br />
- Cardiovascular/renal counter‚Äëregulatory peptide. Early authoritative reviews defined ADM2/IMD as a potent vasodilator with cardiopulmonary and renal protective actions, distinct receptor selectivity across CLR/RAMP complexes, and low basal plasma levels consistent with autocrine/paracrine roles. (https://doi.org/10.1038/sj.bjp.0707494, Mar 2008) (bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2)<br />
- Vascular homeostasis. A 2014 review framed ADM2 as an autocrine/paracrine regulator of vascular homeostasis‚Äîenhancing barrier function, pro‚Äëangiogenesis and anti‚Äëoxidative/ER‚Äëstress responses‚Äîvia CLR/RAMP signaling with cAMP/NO pathways. (https://doi.org/10.1007/s11427-014-4701-7, Aug 2014) (ni2014intermedinadrenomedullin2anautocrineparacrine pages 2-4, ni2014intermedinadrenomedullin2anautocrineparacrine pages 1-2)<br />
- Translational framing in HF and sepsis. Clinical reviews emphasize bio‚ÄëADM as a congestion biomarker and discuss the Adrecizumab concept to rebalance compartmental ADM; they also outline the need for definitive outcome trials. (https://doi.org/10.1002/ejhf.1366, Dec 2019; https://doi.org/10.3389/fimmu.2018.00292, Feb 2018) (voors2019adrenomedullininheart pages 6-7, voors2019adrenomedullininheart pages 6-6, voors2019adrenomedullininheart pages 3-4, geven2018adrenomedullinandadrenomedullintargeted pages 1-2)<br />
- 2024 RAMP perspective. A 2024 mechanistic review argues for targeting specific GPCR/RAMP complexes to achieve desired metabolic and cardiovascular outcomes, citing evidence of RAMP‚Äëdependent signaling bias and tissue‚Äëspecific RAMP expression that conditions ADM2 responses. (https://doi.org/10.1530/jme-24-0056, Sep 2024) (malcharek2024theroleof pages 31-35, malcharek2024theroleof pages 35-42, malcharek2024theroleof pages 21-26)</p>
<p>Relevant statistics and data<br />
- Circulating levels. Plasma ADM2 is typically low (~100‚Äì200 pg/mL) but rises in pregnancy and under certain stressors such as hypoxia and ER stress, supporting both paracrine and endocrine actions. (https://doi.org/10.1111/bph.13814, Apr 2018) (zhang2018adrenomedullin2intermedina pages 1-3)<br />
- Placental/preeclampsia association. In a second‚Äëtrimester cohort, amniotic fluid ADM2 levels were lower in women who later developed early preeclampsia (n=17) compared with controls (n=12), and placental ADM2‚ÄìCRLR proximity was reduced in preeclampsia (PLA assay). (https://doi.org/10.1210/jc.2016-1333, Sep 2016) (chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 6-7, chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 2-3)<br />
- Bio‚ÄëADM prognostic performance. Bio‚ÄëADM concentrations at presentation and day 7 in ADHF associate with clinical congestion and add predictive value for 60‚Äëday re‚Äëhospitalization beyond standard variables; bio‚ÄëADM is elevated in cardiogenic shock with strong links to impaired hemodynamics and organ dysfunction. (https://doi.org/10.1002/ejhf.1366, Dec 2019) (voors2019adrenomedullininheart pages 3-4)<br />
- Genetic variation. CALCRL I446T (rs369317777) associates with lower systolic blood pressure in healthy carriers and worse renal outcomes in diabetes; in iPSC‚ÄëEC models the variant reduces AM‚Äëinduced cAMP efficacy, highlighting functional impact of naturally occurring receptor variation. (2024 thesis) (reith2024characterisationofa pages 23-27)</p>
<p>Molecular function and pathway placement<br />
- Primary role. ADM2 is a secreted signaling peptide of the calcitonin/CGRP superfamily. It activates CALCRL/CLR in complex with RAMP2 or RAMP3 (AM1/AM2 receptors) and can also engage CLR/RAMP1 (CGRP receptor) with lower potency; signaling is dominated by Gs/cAMP with context‚Äëdependent recruitment of Ca2+, ERK and NO pathways. Mechanistically, ADM2 regulates vascular tone, endothelial barrier integrity, angiogenesis, and trophoblast invasion, linking to vascular homeostasis, cardiovascular protection and placentation. (https://doi.org/10.1007/s11427-014-4701-7, Aug 2014; https://doi.org/10.1038/sj.bjp.0707494, Mar 2008; https://doi.org/10.1111/bph.13814, Apr 2018) (ni2014intermedinadrenomedullin2anautocrineparacrine pages 2-4, bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2, zhang2018adrenomedullin2intermedina pages 3-4)<br />
- Localization. ADM2 is processed in the secretory pathway and acts primarily in the extracellular space in autocrine/paracrine fashion; expression is documented in endothelial cells, vascular smooth muscle, placenta/trophoblast, kidney, and stressed myocardium/endothelium, with low basal plasma concentrations. (https://doi.org/10.1007/s11427-014-4701-7, Aug 2014; https://doi.org/10.1095/biolreprod.108.074419, Oct 2009; https://doi.org/10.1111/bph.13814, Apr 2018) (ni2014intermedinadrenomedullin2anautocrineparacrine pages 1-2, chauhan2009expressionofadrenomedullin pages 2-3, zhang2018adrenomedullin2intermedina pages 1-3)<br />
- Developmental and disease links. CLR/RAMP pathway integrity is essential for vascular/lymphatic function; human CALCRL mutations and natural variants link to lymphatic dysplasia and altered hemodynamic traits, consistent with ADM/ADM2 family roles in vascular development and homeostasis. (2024 synthesis of prior studies) (reith2024characterisationofa pages 91-93)</p>
<p>Open questions and future directions (guided by recent literature)<br />
- Precise in vivo abundance and receptor‚Äëselective actions of specific ADM2 fragments (IMD1‚Äì53 vs IMD1‚Äì47 vs IMD8‚Äì47) in humans remain to be fully quantified with fragment‚Äëselective assays. (https://doi.org/10.1111/bph.13814, Apr 2018) (zhang2018adrenomedullin2intermedina pages 7-8)<br />
- Definitive clinical outcome trials testing ADM‚Äëaxis modulation (e.g., Adrecizumab) in sepsis and heart failure are needed to validate biomarker‚Äëdriven strategies and mechanistic hypotheses regarding compartmental redistribution. (https://doi.org/10.1002/ejhf.1366, Dec 2019; https://doi.org/10.3389/fimmu.2018.00292, Feb 2018) (voors2019adrenomedullininheart pages 6-7, voors2019adrenomedullininheart pages 6-6, geven2018adrenomedullinandadrenomedullintargeted pages 1-2)<br />
- Context‚Äëspecific targeting of CLR/RAMP complexes (AM1 vs AM2 vs CGRP receptors) may enable tissue‚Äëselective therapies in cardiometabolic disease; RAMP expression maps and human genetic variation should inform indication selection and safety. (https://doi.org/10.1530/jme-24-0056, Sep 2024; 2024 thesis) (malcharek2024theroleof pages 31-35, malcharek2024theroleof pages 35-42, reith2024characterisationofa pages 23-27)</p>
<p>Quick‚Äëreference summary table<br />
| Category | Key Points | Primary Sources (with year) |<br />
|---|---|---|<br />
| Identity &amp; gene | Human ADM2 (Intermedin, IMD) is encoded by a gene at 22q13.33 and translated as a ~148 amino-acid prepro‚Äëpeptide (prepro‚ÄëIMD/Q7Z4H4). It is a member of the CGRP/ADM peptide family and processed to shorter secreted peptides. | [pqac-00000000] 2018, [pqac-00000003] 2008, [pqac-00000004] 2014 |<br />
| Proteolytic processing | The prepropeptide is proteolytically processed to multiple C‚Äëterminal bioactive fragments including IMD1‚Äì53, IMD1‚Äì47 and IMD8‚Äì47; distinct fragments show different receptor potencies and physiological activities. Proteolytic pattern and fragment-specific activity contribute to functional diversity. | [pqac-00000003] 2008, [pqac-00000001] 2014, [pqac-00000000] 2018 |<br />
| Receptors | ADM2/IMD signals via CALCRL (CLR) when partnered with RAMPs: CLR+RAMP2 (AM1), CLR+RAMP3 (AM2) and CLR+RAMP1 (CGRP context); RAMP identity strongly alters ligand affinity and receptor phenotype. ADM2 displays distinct ligand selectivity across CLR/RAMP complexes versus ADM and CGRP. | [pqac-00000001] 2014, [pqac-00000002] 2018, [pqac-00000004] 2014 |<br />
| Signaling | Canonical signaling is Gs‚Äëcoupled ‚Üí AC ‚Üí cAMP; additional pathways include Gq/PLC‚ÜíCa2+, ERK activation and NOS/NO/cGMP effects. RAMP composition can produce biased G‚Äëprotein coupling and alter downstream effector engagement. | [pqac-00000001] 2014, [pqac-00000002] 2018, [pqac-00000005] 2017 |<br />
| Expression &amp; localization | ADM2 is synthesized as a secreted peptide by endothelial cells, vascular smooth muscle, placenta/trophoblast, kidney and some cardiac tissues; plasma levels are low but inducible (e.g., pregnancy, hypoxia). Subcellularly it is processed through secretory pathway and acts in autocrine/paracrine and endocrine modes. | [pqac-00000004] 2014, [pqac-00000021] 2009, [pqac-00000000] 2018 |<br />
| Physiological roles | ADM2 mediates vasodilation and regional blood‚Äëflow modulation, protects endothelial barrier integrity, promotes angiogenesis and confers cardioprotective/anti‚Äëoxidative effects; it also promotes trophoblast invasion and may contribute to placental function. Many actions are consistent with a vascular homeostasis/counter‚Äëregulatory role. | [pqac-00000004] 2014, [pqac-00000003] 2008, [pqac-00000021] 2009, [pqac-00000018] 2016 |<br />
| Recent (2023‚Äì2024) developments | Recent work emphasizes that RAMPs can act as allosteric modulators producing receptor‚Äë and ligand‚Äëspecific bias, identifies naturally occurring CALCRL variants that alter CLR signaling/physiology, and links ADM2/CLR‚ÄìRAMP pathways to metabolic regulation and tissue‚Äëspecific RAMP expression. These findings refine ADM2 pharmacology and suggest context‚Äëdependent signaling. | [pqac-00000006] 2024, [pqac-00000007] 2024, [pqac-00000009] 2024, [pqac-00000010] 2024 |<br />
| Translational / clinical | Bio‚ÄëADM and MR‚ÄëproADM assays are used as biomarkers of congestion and prognosis in heart failure and sepsis; Adrecizumab (N‚Äëterminal ADM‚Äëbinding antibody) is a translational strategy to modulate intravascular vs interstitial ADM activity in sepsis/HF contexts. ADM2 shows pregnancy associations (reduced in preeclampsia) but clinical ADM2‚Äëspecific therapeutics are not yet established. | [pqac-00000015] 2019, [pqac-00000020] 2018, [pqac-00000018] 2016, [pqac-00000017] 2019 |</p>
<p><em>Table: A concise reference table summarizing ADM2 (Intermedin) identity, processing, receptors, signaling, expression, physiology, recent 2023‚Äì2024 developments, and translational/clinical notes with source IDs for quick citation.</em></p>
<p>References (with URLs and dates inline; bracketed IDs correspond to cited context)<br />
- Zhang S‚ÄëY et al. Br J Pharmacol. Apr 2018. https://doi.org/10.1111/bph.13814 (zhang2018adrenomedullin2intermedina pages 1-3, zhang2018adrenomedullin2intermedina pages 3-4, zhang2018adrenomedullin2intermedina pages 7-8)<br />
- Ni XQ et al. Sci China Life Sci. Aug 2014. https://doi.org/10.1007/s11427-014-4701-7 (ni2014intermedinadrenomedullin2anautocrineparacrine pages 2-4, ni2014intermedinadrenomedullin2anautocrineparacrine pages 1-2)<br />
- Bell D, McDermott B. Br J Pharmacol. Mar 2008. https://doi.org/10.1038/sj.bjp.0707494 (bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2)<br />
- Sch√∂nauer R et al. J Pept Sci. Jul 2017. https://doi.org/10.1002/psc.2953 (schonauer2017adrenomedullin‚Äìnew pages 2-2)<br />
- Malcharek MA et al. J Mol Endocrinol. Sep 2024. https://doi.org/10.1530/jme-24-0056 (malcharek2024theroleof pages 31-35, malcharek2024theroleof pages 35-42, malcharek2024theroleof pages 13-17, malcharek2024theroleof pages 21-26)<br />
- Reith EG. Thesis on CALCRL variant, 2024. (Repository URL not provided in excerpt) (reith2024characterisationofa pages 8-14, reith2024characterisationofa pages 91-93, reith2024characterisationofa pages 23-27)<br />
- Geven C et al. Front Immunol. Feb 2018. https://doi.org/10.3389/fimmu.2018.00292 (geven2018adrenomedullinandadrenomedullintargeted pages 1-2)<br />
- Voors AA et al. Eur J Heart Fail. Dec 2019. https://doi.org/10.1002/ejhf.1366 (voors2019adrenomedullininheart pages 6-7, voors2019adrenomedullininheart pages 6-6, voors2019adrenomedullininheart pages 3-4)<br />
- Chauhan M et al. Biol Reprod. Oct 2009. https://doi.org/10.1095/biolreprod.108.074419 (chauhan2009expressionofadrenomedullin pages 2-3)<br />
- Chauhan M et al. J Clin Endocrinol Metab. Sep 2016. https://doi.org/10.1210/jc.2016-1333 (chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 6-7, chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 2-3)</p>
<p>References</p>
<ol>
<li>
<p>(zhang2018adrenomedullin2intermedina pages 1-3): Song‚ÄêYang Zhang, Ming‚ÄêJiang Xu, and Xian Wang. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases. British Journal of Pharmacology, 175:1230-1240, Apr 2018. URL: https://doi.org/10.1111/bph.13814, doi:10.1111/bph.13814. This article has 63 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(bell2008intermedin(adrenomedullin‚Äê2)a pages 1-2): David Bell and B. McDermott. Intermedin (adrenomedullin‚Äê2): a novel counter‚Äêregulatory peptide in the cardiovascular and renal systems. British Journal of Pharmacology, Mar 2008. URL: https://doi.org/10.1038/sj.bjp.0707494, doi:10.1038/sj.bjp.0707494. This article has 154 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(ni2014intermedinadrenomedullin2anautocrineparacrine pages 1-2): XianQiang Ni, JinSheng Zhang, ChaoShu Tang, and YongFen Qi. Intermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease. Science China Life Sciences, 57:781-789, Aug 2014. URL: https://doi.org/10.1007/s11427-014-4701-7, doi:10.1007/s11427-014-4701-7. This article has 44 citations.</p>
</li>
<li>
<p>(ni2014intermedinadrenomedullin2anautocrineparacrine pages 2-4): XianQiang Ni, JinSheng Zhang, ChaoShu Tang, and YongFen Qi. Intermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease. Science China Life Sciences, 57:781-789, Aug 2014. URL: https://doi.org/10.1007/s11427-014-4701-7, doi:10.1007/s11427-014-4701-7. This article has 44 citations.</p>
</li>
<li>
<p>(zhang2018adrenomedullin2intermedina pages 3-4): Song‚ÄêYang Zhang, Ming‚ÄêJiang Xu, and Xian Wang. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases. British Journal of Pharmacology, 175:1230-1240, Apr 2018. URL: https://doi.org/10.1111/bph.13814, doi:10.1111/bph.13814. This article has 63 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(schonauer2017adrenomedullin‚Äìnew pages 2-2): Ria Sch√∂nauer, Sylvia Els‚ÄêHeindl, and Annette G. Beck‚ÄêSickinger. Adrenomedullin ‚Äì new perspectives of a potent peptide hormone. Journal of Peptide Science, 23:472-485, Jul 2017. URL: https://doi.org/10.1002/psc.2953, doi:10.1002/psc.2953. This article has 92 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(malcharek2024theroleof pages 31-35): Milena A Malcharek, Abigail Pearce, Cheryl A Brighton, David C Hornigold, and Graham Ladds. The role of receptor activity-modifying proteins in obesity and diabetes mellitus. Journal of Molecular Endocrinology, Sep 2024. URL: https://doi.org/10.1530/jme-24-0056, doi:10.1530/jme-24-0056. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(malcharek2024theroleof pages 35-42): Milena A Malcharek, Abigail Pearce, Cheryl A Brighton, David C Hornigold, and Graham Ladds. The role of receptor activity-modifying proteins in obesity and diabetes mellitus. Journal of Molecular Endocrinology, Sep 2024. URL: https://doi.org/10.1530/jme-24-0056, doi:10.1530/jme-24-0056. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(malcharek2024theroleof pages 21-26): Milena A Malcharek, Abigail Pearce, Cheryl A Brighton, David C Hornigold, and Graham Ladds. The role of receptor activity-modifying proteins in obesity and diabetes mellitus. Journal of Molecular Endocrinology, Sep 2024. URL: https://doi.org/10.1530/jme-24-0056, doi:10.1530/jme-24-0056. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(reith2024characterisationofa pages 8-14): EG Reith. Characterisation of a naturally occurring calcitonin receptor-like receptor variant. Unknown journal, 2024.</p>
</li>
<li>
<p>(reith2024characterisationofa pages 23-27): EG Reith. Characterisation of a naturally occurring calcitonin receptor-like receptor variant. Unknown journal, 2024.</p>
</li>
<li>
<p>(reith2024characterisationofa pages 91-93): EG Reith. Characterisation of a naturally occurring calcitonin receptor-like receptor variant. Unknown journal, 2024.</p>
</li>
<li>
<p>(malcharek2024theroleof pages 13-17): Milena A Malcharek, Abigail Pearce, Cheryl A Brighton, David C Hornigold, and Graham Ladds. The role of receptor activity-modifying proteins in obesity and diabetes mellitus. Journal of Molecular Endocrinology, Sep 2024. URL: https://doi.org/10.1530/jme-24-0056, doi:10.1530/jme-24-0056. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(voors2019adrenomedullininheart pages 3-4): Adriaan A. Voors, Daan Kremer, Christopher Geven, Jozine M. ter Maaten, Joachim Struck, Andreas Bergmann, Peter Pickkers, Marco Metra, Alexandre Mebazaa, Hans‚ÄêDirk D√ºngen, and Javed Butler. Adrenomedullin in heart failure: pathophysiology and therapeutic application. European Journal of Heart Failure, 21:163-171, Dec 2019. URL: https://doi.org/10.1002/ejhf.1366, doi:10.1002/ejhf.1366. This article has 255 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(geven2018adrenomedullinandadrenomedullintargeted pages 1-2): Christopher Geven, Matthijs Kox, and Peter Pickkers. Adrenomedullin and adrenomedullin-targeted therapy as treatment strategies relevant for sepsis. Frontiers in Immunology, Feb 2018. URL: https://doi.org/10.3389/fimmu.2018.00292, doi:10.3389/fimmu.2018.00292. This article has 156 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(voors2019adrenomedullininheart pages 6-7): Adriaan A. Voors, Daan Kremer, Christopher Geven, Jozine M. ter Maaten, Joachim Struck, Andreas Bergmann, Peter Pickkers, Marco Metra, Alexandre Mebazaa, Hans‚ÄêDirk D√ºngen, and Javed Butler. Adrenomedullin in heart failure: pathophysiology and therapeutic application. European Journal of Heart Failure, 21:163-171, Dec 2019. URL: https://doi.org/10.1002/ejhf.1366, doi:10.1002/ejhf.1366. This article has 255 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(voors2019adrenomedullininheart pages 6-6): Adriaan A. Voors, Daan Kremer, Christopher Geven, Jozine M. ter Maaten, Joachim Struck, Andreas Bergmann, Peter Pickkers, Marco Metra, Alexandre Mebazaa, Hans‚ÄêDirk D√ºngen, and Javed Butler. Adrenomedullin in heart failure: pathophysiology and therapeutic application. European Journal of Heart Failure, 21:163-171, Dec 2019. URL: https://doi.org/10.1002/ejhf.1366, doi:10.1002/ejhf.1366. This article has 255 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(chauhan2009expressionofadrenomedullin pages 2-3): Madhu Chauhan, Uma Yallampalli, Yuan-Lin Dong, Gary D.V. Hankins, and Chandrasekhar Yallampalli. Expression of adrenomedullin 2 (adm2)/intermedin (imd) in human placenta: role in trophoblast invasion and migration1. Biology of Reproduction, 81:777-783, Oct 2009. URL: https://doi.org/10.1095/biolreprod.108.074419, doi:10.1095/biolreprod.108.074419. This article has 54 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 6-7): Madhu Chauhan, Meena Balakrishnan, Alex Vidaeff, Uma Yallampalli, Fernando Lugo, Karin Fox, Michael Belfort, and Chandra Yallampalli. Adrenomedullin2 (adm2)/intermedin (imd): a potential role in the pathophysiology of preeclampsia. The Journal of clinical endocrinology and metabolism, 101 11:4478-4488, Sep 2016. URL: https://doi.org/10.1210/jc.2016-1333, doi:10.1210/jc.2016-1333. This article has 15 citations.</p>
</li>
<li>
<p>(chauhan2016adrenomedullin2(adm2)intermedin(imd) pages 2-3): Madhu Chauhan, Meena Balakrishnan, Alex Vidaeff, Uma Yallampalli, Fernando Lugo, Karin Fox, Michael Belfort, and Chandra Yallampalli. Adrenomedullin2 (adm2)/intermedin (imd): a potential role in the pathophysiology of preeclampsia. The Journal of clinical endocrinology and metabolism, 101 11:4478-4488, Sep 2016. URL: https://doi.org/10.1210/jc.2016-1333, doi:10.1210/jc.2016-1333. This article has 15 citations.</p>
</li>
<li>
<p>(zhang2018adrenomedullin2intermedina pages 7-8): Song‚ÄêYang Zhang, Ming‚ÄêJiang Xu, and Xian Wang. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases. British Journal of Pharmacology, 175:1230-1240, Apr 2018. URL: https://doi.org/10.1111/bph.13814, doi:10.1111/bph.13814. This article has 63 citations and is from a highest quality peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>reith2024characterisationofa pages 91-93</li>
<li>malcharek2024theroleof pages 13-17</li>
<li>voors2019adrenomedullininheart pages 3-4</li>
<li>reith2024characterisationofa pages 23-27</li>
<li>geven2018adrenomedullinandadrenomedullintargeted pages 1-2</li>
<li>chauhan2009expressionofadrenomedullin pages 2-3</li>
<li>malcharek2024theroleof pages 31-35</li>
<li>malcharek2024theroleof pages 35-42</li>
<li>malcharek2024theroleof pages 21-26</li>
<li>reith2024characterisationofa pages 8-14</li>
<li>voors2019adrenomedullininheart pages 6-7</li>
<li>voors2019adrenomedullininheart pages 6-6</li>
<li>pqac-00000000</li>
<li>pqac-00000003</li>
<li>pqac-00000004</li>
<li>pqac-00000001</li>
<li>pqac-00000002</li>
<li>pqac-00000005</li>
<li>pqac-00000021</li>
<li>pqac-00000018</li>
<li>pqac-00000006</li>
<li>pqac-00000007</li>
<li>pqac-00000009</li>
<li>pqac-00000010</li>
<li>pqac-00000015</li>
<li>pqac-00000020</li>
<li>pqac-00000017</li>
<li>https://doi.org/10.1111/bph.13814,</li>
<li>https://doi.org/10.1038/sj.bjp.0707494,</li>
<li>https://doi.org/10.1007/s11427-014-4701-7,</li>
<li>https://doi.org/10.1002/psc.2953,</li>
<li>https://doi.org/10.1530/jme-24-0056,</li>
<li>https://doi.org/10.1002/ejhf.1366,</li>
<li>https://doi.org/10.3389/fimmu.2018.00292,</li>
<li>https://doi.org/10.1095/biolreprod.108.074419,</li>
<li>https://doi.org/10.1210/jc.2016-1333,</li>
<li>https://doi.org/10.1111/bph.13814</li>
<li>https://doi.org/10.1007/s11427-014-4701-7</li>
<li>https://doi.org/10.1038/sj.bjp.0707494</li>
<li>https://doi.org/10.1002/psc.2953</li>
<li>https://doi.org/10.1530/jme-24-0056</li>
<li>https://doi.org/10.3389/fimmu.2018.00292</li>
<li>https://doi.org/10.1002/ejhf.1366</li>
<li>https://doi.org/10.1095/biolreprod.108.074419</li>
<li>https://doi.org/10.1210/jc.2016-1333</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q7Z4H4
gene_symbol: ADM2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  ADM2 (Adrenomedullin-2/Intermedin) encodes a secreted peptide hormone of the
  calcitonin/CGRP superfamily. The 148 amino acid prepro-protein is proteolytically
  processed to generate bioactive C-terminal peptides including IMD1-53, IMD1-47, and
  IMD8-47. ADM2 functions as a ligand for CALCRL/RAMP receptor complexes (AM1, AM2,
  and CGRP receptors), where RAMP identity determines receptor affinity and signaling
  bias. Canonical signaling is via Gs-coupled adenylyl cyclase/cAMP pathway, with
  additional engagement of Gq/Ca2+, ERK, and NOS/NO pathways. ADM2 acts as a potent
  vasodilator regulating systemic blood pressure, promotes angiogenesis, protects
  endothelial barrier integrity, and has roles in cardiovascular and renal homeostasis.
  It functions primarily in autocrine/paracrine mode with low basal plasma levels.
existing_annotations:
  - term:
      id: GO:0005179
      label: hormone activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2/Intermedin is a well-established peptide hormone of the calcitonin/CGRP
        family that signals through CALCRL/RAMP receptor complexes. The IBA annotation
        is phylogenetically sound and consistent with experimental data showing ADM2
        activates cAMP-dependent pathways through these receptors [PMID:14615490,
        PMID:32296767].
      action: ACCEPT
      reason: &gt;-
        Core function of ADM2 as a hormone is strongly supported by primary literature.
        ADM2 is synthesized as a prepropeptide and processed to secreted bioactive
        peptides that act as ligands for GPCR complexes, fulfilling the definition
        of hormone activity.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.&#34;
        - reference_id: PMID:32296767
          supporting_text: &#34;In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively&#34;
  - term:
      id: GO:0005615
      label: extracellular space
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2 is a secreted peptide hormone that functions in the extracellular space
        to activate CALCRL/RAMP receptors. This is consistent with its signal peptide,
        secretory pathway processing, and autocrine/paracrine mode of action [PMID:14615490].
      action: ACCEPT
      reason: &gt;-
        The extracellular space localization is correct for a secreted hormone that
        acts on cell surface receptors. UniProt confirms secreted localization.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors&#34;
  - term:
      id: GO:0035809
      label: regulation of urine volume
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2/Intermedin has documented roles in renal function and diuresis, consistent
        with the broader adrenomedullin family. The deep research notes ADM2 has
        cardiopulmonary and renal protective actions [file:human/ADM2/ADM2-deep-research-falcon.md].
      action: KEEP_AS_NON_CORE
      reason: &gt;-
        While ADM2 does affect renal function including urine volume, this represents
        a downstream physiological consequence of its vasodilatory and blood pressure
        regulatory effects rather than a core molecular function. The primary role
        is as a vasoactive hormone signaling through CALCRL/RAMP.
      supported_by:
        - reference_id: file:human/ADM2/ADM2-deep-research-falcon.md
          supporting_text: &#34;ADM2/IMD as a potent vasodilator with cardiopulmonary and renal protective actions&#34;
  - term:
      id: GO:1990410
      label: adrenomedullin receptor signaling pathway
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2 is a bona fide ligand for the adrenomedullin receptors (CALCRL+RAMP2/3).
        The IBA annotation is phylogenetically supported and consistent with structural
        and biochemical data showing ADM2 binding and activation of these receptors
        [PMID:14615490, PMID:32296767].
      action: ACCEPT
      reason: &gt;-
        Core function of ADM2 is to act as a ligand in the adrenomedullin receptor
        signaling pathway. This is directly supported by cryo-EM structures of
        ADM2 in complex with AM2R.
      supported_by:
        - reference_id: PMID:32296767
          supporting_text: &#34;In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively&#34;
        - reference_id: PMID:14615490
          supporting_text: &#34;treatment of 293T cells expressing recombinant calcitonin receptor-like receptor (CRLR) and one of the three receptor activity-modifying proteins (RAMPs) showed that a CRLR/RAMP receptor complex is required for intermedin signaling&#34;
  - term:
      id: GO:0003073
      label: regulation of systemic arterial blood pressure
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2/Intermedin is a potent vasodilator that reduces systemic arterial blood
        pressure. In vivo studies demonstrated blood pressure reduction in both normal
        and spontaneously hypertensive rats [PMID:14615490].
      action: ACCEPT
      reason: &gt;-
        Blood pressure regulation is a core physiological function of ADM2, directly
        linked to its vasodilatory activity through CALCRL/RAMP signaling.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats via interactions with the CRLR/RAMP receptor complexes&#34;
  - term:
      id: GO:0007189
      label: adenylate cyclase-activating G protein-coupled receptor signaling pathway
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2 signals through CALCRL/RAMP receptor complexes coupled to Gs, leading
        to adenylyl cyclase activation and cAMP production. This is the canonical
        downstream signaling pathway [PMID:14615490].
      action: ACCEPT
      reason: &gt;-
        This accurately describes the primary signaling mechanism of ADM2. As a
        ligand for CALCRL/RAMP GPCRs, it triggers Gs-coupled adenylyl cyclase
        activation.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors&#34;
  - term:
      id: GO:0010460
      label: positive regulation of heart rate
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        ADM2/Intermedin has documented cardiovascular effects including effects on
        heart rate. The literature indicates ADM2 is important for homeostasis in
        diverse tissues including cardiovascular [PMID:14615490].
      action: KEEP_AS_NON_CORE
      reason: &gt;-
        While ADM2 does have cardiovascular effects that may include heart rate
        modulation, this represents a downstream physiological consequence rather
        than a core molecular function. The primary functions are hormone activity,
        receptor signaling, and blood pressure regulation.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Calcitonin, calcitonin gene-related peptide (CGRP), adrenomedullin (ADM), and amylin belong to a unique group of peptide hormones important for homeostasis in diverse tissues&#34;
  - term:
      id: GO:0005179
      label: hormone activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: &gt;-
        This IEA annotation from UniProt keyword mapping correctly identifies ADM2
        as having hormone activity. It is redundant with the IBA and IDA annotations
        for the same term.
      action: ACCEPT
      reason: &gt;-
        Correct annotation, though redundant with IBA/IDA evidence for the same term.
        The UniProt keyword mapping is appropriate.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin is a calcitonin/calcitonin gene-related peptide family peptide&#34;
  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: &gt;-
        This IEA annotation from UniProt subcellular location mapping correctly
        places ADM2 in the extracellular region. Consistent with its secreted nature.
      action: ACCEPT
      reason: &gt;-
        Correct annotation. ADM2 is a secreted protein and functions in the extracellular
        region. This is a broader parent term of extracellular space (GO:0005615).
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors&#34;
  - term:
      id: GO:0007189
      label: adenylate cyclase-activating G protein-coupled receptor signaling pathway
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: &gt;-
        This IEA annotation from Ensembl Compara orthology transfer is consistent
        with the IBA annotation for the same term. Redundant but correct.
      action: ACCEPT
      reason: &gt;-
        Correct annotation, redundant with IBA evidence. The orthology-based transfer
        is appropriate for this conserved signaling function.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin increased cAMP production in SK-N-MC and L6 cells&#34;
  - term:
      id: GO:0007631
      label: feeding behavior
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: &gt;-
        The original PMID:14615490 reports that intermedin treatment in mice led
        to suppression of food intake, supporting a role in feeding behavior regulation.
        This IEA is transferred from rat ortholog evidence.
      action: KEEP_AS_NON_CORE
      reason: &gt;-
        While ADM2 does affect feeding behavior (suppresses food intake and gastric
        emptying per PMID:14615490), this is not a core molecular function but rather
        a downstream physiological effect of its neuroendocrine activity. The primary
        function is as a vasoactive hormone.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake&#34;
  - term:
      id: GO:0045776
      label: negative regulation of blood pressure
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: &gt;-
        ADM2 is a potent vasodilator that reduces blood pressure. This is well
        supported by PMID:14615490 showing blood pressure reduction in normal
        and hypertensive rats.
      action: ACCEPT
      reason: &gt;-
        Correct and important annotation. ADM2 is a vasodilator that negatively
        regulates blood pressure. This is a core physiological function consistent
        with its role as a vasoactive hormone.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats&#34;
  - term:
      id: GO:0005179
      label: hormone activity
    evidence_type: IDA
    original_reference_id: PMID:32296767
    review:
      summary: &gt;-
        PMID:32296767 provides structural evidence of ADM2 (intermedin) in complex
        with AM2 receptor and Gs protein at 2.3 angstrom resolution, demonstrating
        it functions as a hormone ligand for this receptor complex.
      action: ACCEPT
      reason: &gt;-
        Strong structural evidence supporting hormone activity. The cryo-EM structure
        directly shows ADM2 peptide bound to and activating the receptor complex.
      supported_by:
        - reference_id: PMID:32296767
          supporting_text: &#34;In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively&#34;
  - term:
      id: GO:0005615
      label: extracellular space
    evidence_type: IDA
    original_reference_id: PMID:14615490
    review:
      summary: &gt;-
        PMID:14615490 demonstrates that intermedin acts on cell surface receptors
        to activate intracellular signaling (cAMP production), indicating it
        functions in the extracellular space.
      action: ACCEPT
      reason: &gt;-
        Appropriate localization for a secreted peptide hormone that activates
        cell surface receptors.
      supported_by:
        - reference_id: PMID:14615490
          supporting_text: &#34;Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors and competed with labeled CGRP for binding to its receptors in these cells&#34;
  - term:
      id: GO:1990410
      label: adrenomedullin receptor signaling pathway
    evidence_type: IDA
    original_reference_id: PMID:32296767
    review:
      summary: &gt;-
        PMID:32296767 provides direct structural evidence of ADM2 bound to the
        AM2 receptor (CALCRL+RAMP3) in complex with Gs protein, demonstrating
        its involvement in adrenomedullin receptor signaling.
      action: ACCEPT
      reason: &gt;-
        High-resolution structural evidence directly demonstrates ADM2 engagement
        with the adrenomedullin receptor signaling pathway.
      supported_by:
        - reference_id: PMID:32296767
          supporting_text: &#34;In this study, we report the cryo-EM structure of the AM1R in complex with AM and Gs at a global resolution of 3.0 √Ö, and structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively&#34;
  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-379044
    review:
      summary: &gt;-
        Reactome pathway annotation placing ADM2 in the extracellular region as
        part of the Gs-activating GPCR signaling complex. Consistent with its
        role as a secreted hormone ligand.
      action: ACCEPT
      reason: &gt;-
        Correct localization. ADM2 is a secreted ligand that functions in the
        extracellular region where it binds to cell surface receptors.
  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-420214
    review:
      summary: &gt;-
        Reactome annotation specifically documenting that intermedin (ADM2) binds
        to the adrenomedullin receptor in the extracellular region.
      action: ACCEPT
      reason: &gt;-
        Directly relevant Reactome annotation. The reaction specifically describes
        ADM2/intermedin binding to adrenomedullin receptors.
  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-744886
    review:
      summary: &gt;-
        Reactome annotation for ligand:GPCR:Gs complex dissociation, placing
        ADM2 in the extracellular region. Redundant with other extracellular
        region annotations.
      action: ACCEPT
      reason: &gt;-
        Correct localization, though redundant with multiple other annotations
        for the same term.
  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-744887
    review:
      summary: &gt;-
        Reactome annotation for liganded Gs-activating GPCRs binding inactive
        heterotrimeric Gs. Places ADM2 as extracellular ligand.
      action: ACCEPT
      reason: &gt;-
        Correct localization, though redundant with multiple other annotations
        for the same term.
  - term:
      id: GO:0001525
      label: angiogenesis
    evidence_type: IDA
    original_reference_id: PMID:20596610
    review:
      summary: &gt;-
        PMID:20596610 demonstrates that intermedin (IMD) exerts a pro-angiogenic
        effect on human vascular endothelial cells cultured on Matrigel, mediated
        through CLR/RAMP1 and CLR/RAMP2 receptors.
      action: KEEP_AS_NON_CORE
      reason: &gt;-
        While ADM2 does promote angiogenesis, this is a downstream biological process
        resulting from its signaling activity rather than a core molecular function.
        The core function is hormone activity through receptor signaling. The more
        specific term GO:0045766 (positive regulation of angiogenesis) better captures
        the regulatory nature of this activity.
      supported_by:
        - reference_id: PMID:20596610
          supporting_text: &#34;IMD exerted a significant in vitro angiogenic action, specifically triggered by the binding of the peptide to CLR/RAMP complexes&#34;
  - term:
      id: GO:0006468
      label: protein phosphorylation
    evidence_type: IDA
    original_reference_id: PMID:20596610
    review:
      summary: &gt;-
        OVER-ANNOTATION: ADM2 is a secreted peptide hormone that acts as a LIGAND
        for GPCR receptors (CALCRL/RAMP complexes). It has NO kinase activity.
        PMID:20596610 shows ADM2 treatment leads to increased VEGF receptor-2
        phosphorylation, but ADM2 does not catalyze phosphorylation itself - it
        triggers signaling that leads to kinase activation.
      action: REMOVE
      reason: &gt;-
        This annotation incorrectly implies ADM2 has a direct role in protein
        phosphorylation. ADM2 is a peptide hormone ligand, not a kinase. The
        phosphorylation observed in PMID:20596610 (VEGFR-2 phosphorylation) is
        a downstream consequence of ADM2 signaling, not a direct function of
        the protein. The GO term &#34;protein phosphorylation&#34; is meant for proteins
        that catalyze phosphorylation reactions.
      supported_by:
        - reference_id: PMID:20596610
          supporting_text: &#34;Western blot analysis, however, showed a significant increase of VEGF receptor-2 phosphorylation as early as 5 min following IMD administration&#34;
  - term:
      id: GO:0010628
      label: positive regulation of gene expression
    evidence_type: IDA
    original_reference_id: PMID:20596610
    review:
      summary: &gt;-
        PMID:20596610 shows that intermedin treatment leads to increased VEGF
        mRNA expression 18h after administration, indicating positive regulation
        of gene expression.
      action: KEEP_AS_NON_CORE
      reason: &gt;-
        While ADM2 does positively regulate gene expression (e.g., VEGF), this
        is a downstream consequence of its receptor signaling activity rather
        than a core molecular function. The term is also quite broad; a more
        specific annotation regarding VEGF expression would be more informative.
      supported_by:
        - reference_id: PMID:20596610
          supporting_text: &#34;a significant increase of vascular endothelial growth factor (VEGF) mRNA expression 18 h following IMD administration&#34;
  - term:
      id: GO:0044877
      label: protein-containing complex binding
    evidence_type: IDA
    original_reference_id: PMID:20596610
    review:
      summary: &gt;-
        This annotation likely refers to ADM2 binding to the CALCRL/RAMP receptor
        complex. While technically accurate, &#34;protein-containing complex binding&#34;
        is a very general term that does not adequately describe the specific
        hormone-receptor interaction.
      action: MODIFY
      reason: &gt;-
        This term is too vague and uninformative. ADM2 specifically binds to
        CALCRL/RAMP receptor complexes as a hormone ligand. The &#34;hormone activity&#34;
        annotation better captures this function. If a binding term is needed,
        a more specific term like G protein-coupled receptor binding would be
        more appropriate, though the hormone activity annotation already implies
        receptor binding.
      proposed_replacement_terms:
        - id: GO:0001664
          label: G protein-coupled receptor binding
      supported_by:
        - reference_id: PMID:20596610
          supporting_text: &#34;IMD exerted a significant in vitro angiogenic action, specifically triggered by the binding of the peptide to CLR/RAMP complexes&#34;
  - term:
      id: GO:0045766
      label: positive regulation of angiogenesis
    evidence_type: IDA
    original_reference_id: PMID:19592612
    review:
      summary: &gt;-
        PMID:19592612 provides strong evidence that intermedin promotes angiogenesis
        through multiple mechanisms including increased blood perfusion, capillary
        and arteriole density in ischemic hindlimb, endothelial cell migration
        and tube formation, mediated via ERK, Akt/NOS/NO, and VEGF/VEGFR-2 pathways.
      action: KEEP_AS_NON_CORE
      reason: &gt;-
        ADM2 does positively regulate angiogenesis, which is a significant
        biological function. However, this represents a downstream effect of
        its hormone signaling activity rather than the core molecular function.
        The primary functions are hormone activity and receptor signaling.
      supported_by:
        - reference_id: PMID:19592612
          supporting_text: &#34;IMD gene delivery also increased capillary and arteriole density in ischemic hindlimb&#34;
        - reference_id: PMID:19592612
          supporting_text: &#34;In cultured endothelial cells, IMD induced cell migration and tube formation&#34;
references:
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
    findings: []
  - id: GO_REF:0000044
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
      Location vocabulary mapping, accompanied by conservative changes to GO
      terms applied by UniProt
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation
      data to orthologs using Ensembl Compara
    findings: []
  - id: PMID:14615490
    title: Intermedin is a calcitonin/calcitonin gene-related peptide family
      peptide acting through the calcitonin receptor-like receptor/receptor
      activity-modifying protein receptor complexes.
    findings:
      - statement: ADM2/Intermedin is a novel member of the calcitonin/CGRP peptide family
        supporting_text: &#34;Intermedin is a calcitonin/calcitonin gene-related peptide family peptide&#34;
      - statement: Expressed primarily in pituitary and gastrointestinal tract
        supporting_text: &#34;intermedin is expressed primarily in the pituitary and gastrointestinal tract&#34;
      - statement: Signals through CRLR/RAMP receptor complexes
        supporting_text: &#34;a CRLR/RAMP receptor complex is required for intermedin signaling&#34;
      - statement: Increases cAMP production
        supporting_text: &#34;Intermedin increased cAMP production in SK-N-MC and L6 cells&#34;
      - statement: Acts as a nonselective agonist for RAMP coreceptors
        supporting_text: &#34;intermedin represents a nonselective agonist for the RAMP coreceptors&#34;
      - statement: Reduces blood pressure in normal and hypertensive rats
        supporting_text: &#34;intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats&#34;
      - statement: Suppresses gastric emptying and food intake
        supporting_text: &#34;in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake&#34;
  - id: PMID:19592612
    title: Intermedin is a new angiogenic growth factor.
    findings:
      - statement: IMD promotes angiogenesis in ischemic hindlimb
        supporting_text: &#34;IMD gene delivery also increased capillary and arteriole density in ischemic hindlimb&#34;
      - statement: Increases capillary and arteriole density
        supporting_text: &#34;increased capillary and arteriole density in ischemic hindlimb, identified by anti-CD-31 and alpha-smooth muscle actin immunostaining&#34;
      - statement: Induces endothelial cell migration and tube formation
        supporting_text: &#34;In cultured endothelial cells, IMD induced cell migration and tube formation&#34;
      - statement: Effects mediated via ERK, Akt/NOS/NO, and VEGF/VEGFR-2 pathways
        supporting_text: &#34;these effects were blocked by the inhibition of extracellular signal-regulated kinase (ERK), Akt, nitric oxide (NO) synthase (NOS), vascular endothelial growth factor receptor-2 (VEGFR-2)&#34;
  - id: PMID:20596610
    title: Involvement of vascular endothelial growth factor signaling in
      CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on
      human vascular endothelial cells.
    findings:
      - statement: IMD exerts pro-angiogenic effects on HUVECs
        supporting_text: &#34;IMD exerted a significant in vitro angiogenic action&#34;
      - statement: Mediated through CLR/RAMP1 and CLR/RAMP2 receptors
        supporting_text: &#34;Both CLR/RAMP1 and CLR/RAMP2 appeared to mediate the pro-angiogenic effect&#34;
      - statement: Increases VEGF mRNA expression
        supporting_text: &#34;a significant increase of vascular endothelial growth factor (VEGF) mRNA expression 18 h following IMD administration&#34;
      - statement: Induces VEGFR-2 phosphorylation
        supporting_text: &#34;a significant increase of VEGF receptor-2 phosphorylation as early as 5 min following IMD administration&#34;
  - id: PMID:32296767
    title: Structure and Dynamics of Adrenomedullin Receptors AM(1) and AM(2)
      Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor
      Activity-Modifying Proteins.
    findings:
      - statement: Cryo-EM structure of AM2R in complex with intermedin/ADM2 at 2.3 angstrom
        supporting_text: &#34;structures of the AM2R in complex with either AM or intermedin/adrenomedullin 2 (AM2) and Gs at 2.4 and 2.3 √Ö, respectively&#34;
      - statement: Reveals mechanisms of RAMP modulation of CLR phenotype
        supporting_text: &#34;Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins&#34;
      - statement: Structural basis for ligand recognition
        supporting_text: &#34;The structures reveal distinctions in the primary orientation of the extracellular domains (ECDs) relative to the receptor core&#34;
  - id: Reactome:R-HSA-379044
    title: Liganded Gs-activating GPCR acts as a GEF for Gs
    findings: []
  - id: Reactome:R-HSA-420214
    title: The adrenomedullin receptor can bind adrenomedullin and intermedin
    findings: []
  - id: Reactome:R-HSA-744886
    title: The Ligand:GPCR:Gs complex dissociates
    findings: []
  - id: Reactome:R-HSA-744887
    title: Liganded Gs-activating GPCRs bind inactive heterotrimeric Gs
    findings: []
  - id: file:human/ADM2/ADM2-deep-research-falcon.md
    title: Deep research on ADM2 gene
    findings:
      - statement: ADM2 has cardiopulmonary and renal protective actions
        supporting_text: &#34;ADM2/IMD as a potent vasodilator with cardiopulmonary and renal protective actions&#34;
core_functions:
  - description: &gt;-
      ADM2 is fundamentally a peptide hormone. It is synthesized as a prepropeptide,
      proteolytically processed to bioactive fragments, secreted, and acts on target
      cells through cell surface receptors. This is supported by IBA, IEA, and IDA
      evidence including cryo-EM structures showing ADM2 bound to receptor complexes.
    molecular_function:
      id: GO:0005179
      label: hormone activity
    locations:
      - id: GO:0005615
        label: extracellular space
    directly_involved_in:
      - id: GO:1990410
        label: adrenomedullin receptor signaling pathway
      - id: GO:0007189
        label: adenylate cyclase-activating G protein-coupled receptor signaling pathway
      - id: GO:0003073
        label: regulation of systemic arterial blood pressure
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>